Prospects Diminish For Comprehensive Drug Pricing Reform In The Wake Of Internal Clash Among Democrats

October 6, 2021

As Democratic leaders try to establish a politically feasible path forward for the $3.5 trillion budget reconciliation bill, they appear to be caving in to the demands of a small, but influential group of House and Senate centrists who have voiced objections to comprehensive, system-wide drug pricing reform. Last month, there was ample forewarning that the lofty ambitions of top Democrats would be met with resistance from within the party.

Read the source article at forbes.com
2021-10-01 01:00:00

Share This Story!